Quantcast Blood Pressure Medication to Include Warning About Celiac Disease-Like Side Effects | NFCA
Skip Navigation Links

Blood Pressure Medication to Include Warning About Celiac Disease-Like Side Effects

Share |


The U.S. Food and Drug Administration (FDA) released a safety announcement earlier this week warning healthcare providers and consumers about the potential side effects of olmesartan medoxomil, a blood pressure medication that goes by the brand names Benicar, Benicar HCT, Azor, Tribenzor and is also found in generics. According to the FDA, the medication can cause severe chronic diarrhea and weight loss – symptoms often associated with celiac disease. The medication label will now include a warning about this potential reaction.

Celiac disease expert and NFCA Scientific/Medical Advisory Council Member Dr. Joseph Murray of the Mayo Clinic recognized the reaction and reported his concerns in a press release and video published in June 2012. At the time, he encouraged other medical providers to contact the FDA if they identify similar cases. He also advised patients to talk to their doctor if they are experiencing celiac disease-like symptoms while taking olmesartan medoxomil.

For more information, read the FDA’s safety announcement.

Note: NFCA maintains the position that views and information presented on articles and websites we link to are those of the authors, and not necessarily those of NFCA.

<< Back to Research News


  • Have you or your family members been diagnosed?
    Complete our celiac disease symptoms checklist today to find out if you are at risk of having celiac disease or non-celiac gluten sensitivity ('gluten sensitivity').  We can help improve your quality of life!
  • Stay Informed!
    Join our monthly newsletter to receive news, updates, and tips for healthy gluten-free living and information about celiac disease. Sign-up for the monthly e-mail newsletter